✦ LIBER ✦

Wide Variation in Clinicians' Assessment of New York Heart Association/World Health Organization Functional Class in Patients With Pulmonary Arterial Hypertension

✍ Scribed by Taichman, Darren B.; McGoon, Michael D.; Harhay, Michael O.; Archer-Chicko, Chris; Sager, Jeffrey S.; Murugappan, Meena; Chakinali, Murali M.; Palevsky, Harold I.; Gallop, Robert

Book ID: 122928438
Publisher: Mayo Clinic
Year: 2009
Tongue: English
Weight: 162 KB
Volume: 84
Category: Article
ISSN: 0025-6196
DOI: 10.4065/84.7.586

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treprostinil for the Treatment of Pulmon

Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients with New York Heart Association Class II–IV Symptoms

✍ Nicole Herald; Kevin Laliberte 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

A Randomized, Placebo-Controlled Trial A

A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure

✍ Henry J. Dargie; Per R. Hildebrandt; Günter A.J. Riegger; John J.V. McMurray; St 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Rationale, design, and methods for a piv

Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure

✍ Douglas L. Mann; Michael A. Acker; Mariell Jessup; Hani N. Sabbah; Randall C. St 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 274 KB